Prevalence of High Bleeding Risk among Hospitalized Suspected NSTEMI Patients

In recent years, guidelines for the management of acute coronary syndromes (ACS) have placed more emphasis on identifying patients at high bleeding risk (HBR). We set out to investigate the prevalence of HBR patients according to the Academic Research Consortium for High Bleeding Risk (ARC–HBR) crit...

Full description

Bibliographic Details
Main Authors: Henri Kesti, Henna Mäkinen, Kalle Mattila, Samuli Jaakkola, Mikko Lintu, Pekka Porela
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/5/1324
_version_ 1797474714762870784
author Henri Kesti
Henna Mäkinen
Kalle Mattila
Samuli Jaakkola
Mikko Lintu
Pekka Porela
author_facet Henri Kesti
Henna Mäkinen
Kalle Mattila
Samuli Jaakkola
Mikko Lintu
Pekka Porela
author_sort Henri Kesti
collection DOAJ
description In recent years, guidelines for the management of acute coronary syndromes (ACS) have placed more emphasis on identifying patients at high bleeding risk (HBR). We set out to investigate the prevalence of HBR patients according to the Academic Research Consortium for High Bleeding Risk (ARC–HBR) criteria in hospitalized patients with suspected non-ST-segment elevation myocardial infarction (NSTEMI). Consecutive patients were retrospectively enrolled between January and June 2019 from the emergency department (ED) of a tertiary hospital. The discharge diagnosis and baseline data were manually collected using electronic patient records and database searches. Patients with non-cardiac diagnoses were excluded. Overall, 212 patients were included in the study. A total of 146 (68.9%) patients were diagnosed with NSTEMI (Type 1), 47 (22.2%) with unstable angina pectoris (UAP) and 19 (9.0%) with “other.” HBR was detected in 47.6% (<i>n</i> = 101) of all patients. Common criteria for HBR among ACS patients were age (40.4%), chronic kidney disease (33.7%), and the use of oral anticoagulation medicines (20.2%). In conclusion, nearly half of the patients hospitalized for ACS fulfilled HBR criteria. According to contemporary guidelines, the management of HBR patients differs from that of non-HBR patients, and thus, a more comprehensive screening for HBR may be considered in clinical practice.
first_indexed 2024-03-09T20:35:04Z
format Article
id doaj.art-852fa4cd638c403196006564ab0ec529
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T20:35:04Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-852fa4cd638c403196006564ab0ec5292023-11-23T23:14:10ZengMDPI AGJournal of Clinical Medicine2077-03832022-02-01115132410.3390/jcm11051324Prevalence of High Bleeding Risk among Hospitalized Suspected NSTEMI PatientsHenri Kesti0Henna Mäkinen1Kalle Mattila2Samuli Jaakkola3Mikko Lintu4Pekka Porela5Heart Centre, Turku University Hospital and University of Turku, 20521 Turku, FinlandEmergency Department, Turku University Hospital, 20521 Turku, FinlandEmergency Department, Turku University Hospital, 20521 Turku, FinlandHeart Centre, Turku University Hospital and University of Turku, 20521 Turku, FinlandEmergency Department, Turku University Hospital, 20521 Turku, FinlandHeart Centre, Turku University Hospital and University of Turku, 20521 Turku, FinlandIn recent years, guidelines for the management of acute coronary syndromes (ACS) have placed more emphasis on identifying patients at high bleeding risk (HBR). We set out to investigate the prevalence of HBR patients according to the Academic Research Consortium for High Bleeding Risk (ARC–HBR) criteria in hospitalized patients with suspected non-ST-segment elevation myocardial infarction (NSTEMI). Consecutive patients were retrospectively enrolled between January and June 2019 from the emergency department (ED) of a tertiary hospital. The discharge diagnosis and baseline data were manually collected using electronic patient records and database searches. Patients with non-cardiac diagnoses were excluded. Overall, 212 patients were included in the study. A total of 146 (68.9%) patients were diagnosed with NSTEMI (Type 1), 47 (22.2%) with unstable angina pectoris (UAP) and 19 (9.0%) with “other.” HBR was detected in 47.6% (<i>n</i> = 101) of all patients. Common criteria for HBR among ACS patients were age (40.4%), chronic kidney disease (33.7%), and the use of oral anticoagulation medicines (20.2%). In conclusion, nearly half of the patients hospitalized for ACS fulfilled HBR criteria. According to contemporary guidelines, the management of HBR patients differs from that of non-HBR patients, and thus, a more comprehensive screening for HBR may be considered in clinical practice.https://www.mdpi.com/2077-0383/11/5/1324non-ST-segment elevation myocardial infarctionbleedinghigh bleeding riskAcademic Research Consortium
spellingShingle Henri Kesti
Henna Mäkinen
Kalle Mattila
Samuli Jaakkola
Mikko Lintu
Pekka Porela
Prevalence of High Bleeding Risk among Hospitalized Suspected NSTEMI Patients
Journal of Clinical Medicine
non-ST-segment elevation myocardial infarction
bleeding
high bleeding risk
Academic Research Consortium
title Prevalence of High Bleeding Risk among Hospitalized Suspected NSTEMI Patients
title_full Prevalence of High Bleeding Risk among Hospitalized Suspected NSTEMI Patients
title_fullStr Prevalence of High Bleeding Risk among Hospitalized Suspected NSTEMI Patients
title_full_unstemmed Prevalence of High Bleeding Risk among Hospitalized Suspected NSTEMI Patients
title_short Prevalence of High Bleeding Risk among Hospitalized Suspected NSTEMI Patients
title_sort prevalence of high bleeding risk among hospitalized suspected nstemi patients
topic non-ST-segment elevation myocardial infarction
bleeding
high bleeding risk
Academic Research Consortium
url https://www.mdpi.com/2077-0383/11/5/1324
work_keys_str_mv AT henrikesti prevalenceofhighbleedingriskamonghospitalizedsuspectednstemipatients
AT hennamakinen prevalenceofhighbleedingriskamonghospitalizedsuspectednstemipatients
AT kallemattila prevalenceofhighbleedingriskamonghospitalizedsuspectednstemipatients
AT samulijaakkola prevalenceofhighbleedingriskamonghospitalizedsuspectednstemipatients
AT mikkolintu prevalenceofhighbleedingriskamonghospitalizedsuspectednstemipatients
AT pekkaporela prevalenceofhighbleedingriskamonghospitalizedsuspectednstemipatients